MELISSA IRVIN SAHM: Open Payments
NPI 1356978530 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 70 payments from 20 companies in 2025. Trend: 2023 $1,393 · 2024 $1,025 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $246 |
| Novo Nordisk Inc | 14 | $171 |
| ABBVIE INC. | 8 | $144 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $114 |
| Exact Sciences Corporation | 3 | $77 |
| Gilead Sciences, Inc. | 2 | $47 |
| Lilly USA, LLC | 3 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
| Medtronic, Inc. | 2 | $38 |
Products named: NURTEC ODT, Ozempic, Kerendia, QULIPTA, FARXIGA, VRAYLAR, BREZTRI, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
